Medicine guide

Imatinib Devatis 100 mg (teilbar)

As listed in the register: Imatinib Devatis 100 mg (teilbar), Filmtabletten

100 mg ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Imatinibum
Made by
Devatis AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Zytostatikum Ph+ chronische myeloische Leukämie (Ph+CML) Ph+ akute lymphatische Leukämie (Ph+ALL) Hypereosinophilensyndrom (HES/CEL) Atypische myelodysplastische/myeloproliferative Erkrankungen (MDS/MPD) Aggressive systemische Mastozytose (aggr. SM) Gastrointestinale Stromatumoren (GIST) Dermatofibrosarkom protuberans (DFSP) (für genaue Angaben zur Indikation siehe aktuelle Fachinformation

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

Details

Made byDevatis AG
Active substanceImatinibum
Used inCancer treatments and immune-system medicines
Strength100 mg
ClassificationL01XE01 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerImatinib Devatis 100 mg (teilbar), Filmtabletten
Packs30 Tablette(n) · 60 Tablette(n)
Zulassungsnummer65580
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.